M Abu-Zeid
Overview
Explore the profile of M Abu-Zeid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fathy O, Abdel-Wahab M, Elghwalby N, Sultan A, El-Ebidy G, Abu-Zeid M, et al.
Hepatogastroenterology
. 2008 Sep;
55(85):1463-9.
PMID: 18795713
Background/aims: Surgical resection still remains the best treatment for patients with periampullary tumors. This study aims to present the results of surgical treatment of this disease at our center. Methodology:...
2.
Abu-Zeid M, Hori H, Nagasawa H, Uto Y, INAYAMA S
Biol Pharm Bull
. 2000 Mar;
23(2):195-8.
PMID: 10706383
In order to decrease toxicity and/or increase radiosensitizing activity, a new 2-nitroimidazole derivative, methyl 2-nitroimidazole-1-acetohydroxamate (KIN-804), was synthesized to solve the problem of tumor hypoxia. Evaluation of the efficiency of...
3.
Abu-Zeid M, Hori H, Nagasawa H, Uto Y, INAYAMA S
Biol Pharm Bull
. 2000 Mar;
23(2):190-4.
PMID: 10706382
Methyl 2-nitroimidazole-1-acetohydroxamate (KIN-804) is a 2-nitroimidazole derivative containing a hydroxamate side chain designed to enhance the radiosensitization response of hypoxic cells. The possible sensitization of tumor tissue by KIN-804 can...
4.
Yoshioka M, Abu-Zeid M, Kubo T
Biol Pharm Bull
. 1994 Feb;
17(2):169-72.
PMID: 8205111
In an attempt to find an end-point for cancer chemotherapy, this study was designed to measure the adenine compounds in the plasma of breast cancer patients using HPLC with a...
5.
Yamazoe Y, Abu-Zeid M, Staiano N, Kato R
Basic Life Sci
. 1993 Jan;
61:161-9.
PMID: 8304927
No abstract available.
6.
Abu-Zeid M, Yamazoe Y, Kato R
Carcinogenesis
. 1992 Aug;
13(8):1307-14.
PMID: 1499081
Characteristics of cytosolic sulfotransferase-mediated binding of carcinogenic N-hydroxyarylamines(amide) have been investigated and compared among experimental animal species and humans in vitro. Human cytosols exhibited significant sulfating activities towards 2-hydroxyamino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (N-hydroxy-Glu-P-1),...
7.
Abu-Zeid M, Nagata K, Miyata M, Ozawa S, Fukuhara M, Yamazoe Y, et al.
Mol Carcinog
. 1991 Jan;
4(1):81-8.
PMID: 2009137
A cDNA clone (designated hamAT101) encoding an arylamine acetyltransferase, AT-1, was isolated from a hamster liver lambda gt11 cDNA library using a specific polyclonal antibody raised against AT-1. The cloned...
8.
Ozawa S, Abu-Zeid M, Kawakubo Y, Toyama S, Yamazoe Y, Kato R
Carcinogenesis
. 1990 Dec;
11(12):2137-44.
PMID: 2265466
Two forms of cytosolic acetyltransferases, AT-I and AT-II, have been purified from hamster livers, and a comparison made of their chemical and catalytic properties and genetically expressed difference. Homogeneous AT-I...
9.
Abu-Zeid M, Staiano N, Yamazoe Y, Kato R
Jpn J Cancer Res
. 1990 Jun;
81(6-7):653-9.
PMID: 2119366
The effect of thiols on the activation of a pyrolysate-derived N-hydroxyarylamine, 2-hydroxyamino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (N-hydroxy-Glu-P-1), was studied in vitro. In hepatic cytosol of rats, [3H]-N-hydroxy-Glu-P-1 bound covalently to calf thymus DNA in...
10.
Ozawa S, Abu-Zeid M, Murayama N, Yamazoe Y, Kato R
Jpn J Cancer Res
. 1990 Mar;
81(3):247-52.
PMID: 2112527
The mechanism of the alteration in carcinogenic arylamine-activating capacities in livers bearing pre-neoplastic (or hyperplastic) nodules induced by the Solt-Farber protocol was investigated in relation to the changes in hepatic...